Wikisage, the free encyclopedia of the second generation, is digital heritage
Quetiapine: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
Line 8: | Line 8: | ||
Leyla Baysal Kirac, Ibrahim Aydogdu, Ahmet Acarer, Sezin Alpaydin, Fatma Ece Bayam, | Leyla Baysal Kirac, Ibrahim Aydogdu, Ahmet Acarer, Sezin Alpaydin, Fatma Ece Bayam, | ||
Habibe Onbasi, Fikret Bademkiran [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150636/pdf/main.pdf Myoclonic status epilepticus] Epilepsy and behaviour case reports | Habibe Onbasi, Fikret Bademkiran [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150636/pdf/main.pdf Myoclonic status epilepticus] Epilepsy and behaviour case reports | ||
==[[ATC]]== | |||
==Notes== | ==Notes== | ||
<references/> | <references/> |
Revision as of 03:51, 26 August 2017
Quetiapine is indicated for the treatment of bipolar disorder, and has been documented to trigger seizures in the literature [1] [2][3][4] Bipolar disorder; migraines and epilepsy are three prevalent conditions. Co-morbidities often present between two of these conditions[5]
Links
JJ Chen Case Report Diagnosis and Treatment of Psychiatric Comorbidity in a Patient with Charles Bonnet Syndrome Case Reports in Psychiatry
Leyla Baysal Kirac, Ibrahim Aydogdu, Ahmet Acarer, Sezin Alpaydin, Fatma Ece Bayam, Habibe Onbasi, Fikret Bademkiran Myoclonic status epilepticus Epilepsy and behaviour case reports